Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug-Eluting Stents: Revolution In Patient Care Or Excessive Euphoria?

This article was originally published in The Gray Sheet

Executive Summary

Intravascular ultrasound (IVUS) and angiography, used in recent pivotal trials of drug-eluting stents, cannot accurately predict the long term effects of the devices, according to Renu Virmani, MD, Armed Forces Institute of Pathology

You may also be interested in...



Anti-Restenosis Alternative Envisioned By Biodegradable Stent Developers

Biodegradable stent R&D will accelerate as long-term efficacy data on drug-eluting stents becomes available, several presenters predicted at the Cardiovascular Revascularization Therapy conference in Washington, D.C. Jan. 26-29

Anti-Restenosis Alternative Envisioned By Biodegradable Stent Developers

Biodegradable stent R&D will accelerate as long-term efficacy data on drug-eluting stents becomes available, several presenters predicted at the Cardiovascular Revascularization Therapy conference in Washington, D.C. Jan. 26-29

FDA Panel Review Of J&J Cypher Stent Will Weigh SIRIUS Late Loss Data

Johnson & Johnson/Cordis' upcoming presentation before an FDA advisory panel on the Cypher drug-eluting stent will highlight a 67% reduction of target vessel failure (TVF) at nine months compared with bare stents

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel